Zicix (OTCMKTS:ZICXD – Get Free Report) and Danaher (NYSE:DHR – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.
Insider & Institutional Ownership
79.1% of Danaher shares are held by institutional investors. 10.8% of Danaher shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Zicix and Danaher’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Zicix | N/A | N/A | N/A |
| Danaher | 14.89% | 10.91% | 6.94% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Zicix | N/A | N/A | N/A | ($100.14) | -0.01 |
| Danaher | $24.57 billion | 5.18 | $3.61 billion | $5.17 | 34.81 |
Danaher has higher revenue and earnings than Zicix. Zicix is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Zicix has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500. Comparatively, Danaher has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Zicix and Danaher, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Zicix | 0 | 0 | 0 | 0 | 0.00 |
| Danaher | 0 | 5 | 19 | 1 | 2.84 |
Danaher has a consensus price target of $233.61, suggesting a potential upside of 29.82%. Given Danaher’s stronger consensus rating and higher possible upside, analysts plainly believe Danaher is more favorable than Zicix.
Summary
Danaher beats Zicix on 13 of the 13 factors compared between the two stocks.
About Zicix
Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
Receive News & Ratings for Zicix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zicix and related companies with MarketBeat.com's FREE daily email newsletter.
